Studies | EBMT

Top

Study type

Disease

Group

Type of transplant / Cell therapy

Text

Language

Outcomes of CAR T-Cell Therapy Versus Autologous HSCT in Patients with Large B-Cell Lymphoma in Complete Remission

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Remy DULERY

Allogeneic Stem Cell Transplant in Primary CNS Lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Axicabtagene ciloleucel and lisocabtagene maraleucel as second-line treatment for patients with relapsed or refractory DLBCL - a real-world analysis of the lymphoma working party of the EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Anna Ossami SAIDY

Real World Experience of CAR-T in follicular lymphoma: a Lymphoma Working Party-EBMT study

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Leyre BENTO & Dr. Silvia MONTOTO

Non-interventional registry-based analysis in the use of Brentuximab Vedotin and/or Checkpoint inhibitors as bridge to autologous stem cell transplantation in Hodgkin lymphoma.

Non-interventional Prospective Studies

Hodgkin’s Disease (HD)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Ali BAZARBACHI & Dr. Anna SUREDA

Autologous, Allogeneic Stem-Cell Transplantation and CART Cell therapy for Transformed Waldenström Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL) to High Grade NHL (HGNHL)

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Charalampia KYRIAKOU & Dr. Nour MOUKALLED

Stem cell transplantation for ALK-pos. and ALK-neg. anaplastic large cell lymphoma: a retrospective analysis of the EBMT-Lymphoma Working Party

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Evgenii SHUMILOV & Dr. Norbert SCHMITZ

Exploring the Role of AlloHCT in the Modern Era of R/R Mantle Cell Lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Nora LIEBERS & Dr. Sascha DIETRICH

Outcomes after CAR T-cell therapy in Primary Mediastinal B-Cell Lymphoma: a real-world study of the Lymphoma Working Party of the EBMT

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Remy DULERY

Efficacy and safety of checkpoint inhibitors after allogeneic hematopoietic cell transplantation in relapsed/refractory classic Hodgkin lymphoma

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Liudmila Fedorova

Efficacité et sécurité des inhibiteurs de points de contrôle immunitaire après transplantation allogénique de cellules souches hématopoïétiques dans le lymphome de Hodgkin classique en rechute/réfractaire

Études rétrospectives

Lymphome non hodgkinien (LNH)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Dr. Liudmila Fedorova

Retrospective analysis of Autologous and Allogeneic Hematopoietic TRansplantation in Extra Nodal Digestive Peripheral T-cell Lymphoma.

Retrospective Studies

Non-Hodgkin’s Lymphoma (NHL)

Lymphoma Working Party (LWP)

Type of treatment

Principal investigator

Olivier TOURNILHAC